Skip to main content
. 2020 Feb 21;86(6):1165–1175. doi: 10.1111/bcp.14229

Figure 1.

Figure 1

Algorithm designed to make therapeutic decisions based on trough serum concentrations of infliximab, presence of anti‐infliximab antibodies and treatment response. Response is based on clinical, endoscopic and biochemical outcomes. Adapted from reference 12